The DCCT confirmed the importance of intensive insulin therapy versus conventional insulin therapy in improving glycemic levels and reducing the risk of diabetic nephropathy, retinopathy, and neuropathy, as well as long-term adverse cardiovascular outcomes5–7. This evidence concerns the gene INS and neuropathy.